Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy

NCT07234630 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT07234630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07234630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Not yet recruiting
Start date
January 31, 2026
Completion date
February 29, 2028
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disseminated intravascular coagulation, hematologic neoplasms, solid tumor metastatic cancer advanced cancer